Hamilton Lane Incorporated - Class A Common Stock (HLNE)
149.00
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 2nd, 5:43 AM EDT
Detailed Quote
Previous Close
149.00
Open
-
Bid
59.60
Ask
148.60
Day's Range
N/A - N/A
52 Week Range
114.85 - 203.72
Volume
1
Market Cap
-
PE Ratio (TTM)
37.44
EPS (TTM)
4.0
Dividend & Yield
1.960 (1.32%)
1 Month Average Volume
380,816
Chart
About Hamilton Lane Incorporated - Class A Common Stock (HLNE)
Hamilton Lane Inc is a leading investment management firm that specializes in private markets. The company offers a range of services, including advisory, investment management, and market research, tailored to meet the needs of institutional investors and clients seeking to access the private equity and alternative investment landscape. Hamilton Lane leverages its extensive expertise and proprietary technology to provide insights and strategies that help clients navigate complex investment opportunities while aiming to optimize returns and manage risks. The firm is dedicated to enhancing transparency and efficiency in private market investing through innovative solutions and strategic guidance. Read More
Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of President Donald Trump’s tari
Hamilton Lane (NASDAQ:HLNE) excels as a quality investment with high ROIC, strong cash flow, and steady growth, making it a standout in private markets solutions.
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
